Unknown

Dataset Information

Inhibition of IL-17 signaling in macrophages underlies the anti-arthritic effects of halofuginone hydrobromide: Network pharmacology, molecular docking, and experimental validation.


ABSTRACT:

Background

Rheumatoid arthritis (RA) is a prevalent autoimmune disease marked by chronic synovitis as well as cartilage and bone destruction. Halofuginone hydrobromide (HF), a bioactive compound derived from the Chinese herbal plant Dichroa febrifuga Lour., has demonstrated substantial anti-arthritic effects in RA. Nevertheless, the molecular mechanisms responsible for the anti-RA effects of HF remain unclear.

Methods

This study employed a combination of network pharmacology, molecular docking, and experimental validation to investigate potential targets of HF in RA.

Results

Network pharmacology analyses identified 109 differentially expressed genes (DEGs) resulting from HF treatment in RA. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses

SUBMITTER: Zhu J 

PROVIDER: S-EPMC10900594 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature